Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.

× No keyword cloud information.

12 in total

1. Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors: Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal: Hepatol Int Date: 2011-06-14 Impact factor: 6.047

2. Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.

Authors: Wen-Pin Su; Chi-Chung Wen; Chao-A Hsiung; Ih-Jen Su; Ann-Lii Cheng; Ming-Chih Chang; Chao-Jung Tsao; Woei-Yao Kao; Wu-Ching Uen; Chiun Hsu; Chih-Hung Hsu; Yen-Shen Lu; Hwei-Fan Tien; Tsu-Yi Chao; Li-Tzong Chen; Jacqueline Whang-Peng; Pei-Jer Chen
Journal: World J Gastroenterol Date: 2005-09-14 Impact factor: 5.742

3. An argument for the universal prophylaxis of hepatitis B infection in patients receiving rituximab: a 7-year institutional experience of hepatitis screening.

Authors: Christopher Leung; Edward Tsoi; Gareth Burns; William Sievert
Journal: Oncologist Date: 2011-04-04

4. The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies.

Authors: Mitra Mirzaee; Ramin Yaghobi; Mani Ramzi; Mahdi Roshan Nia
Journal: Mol Biol Rep Date: 2011-05-20 Impact factor: 2.316

5. Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.

Authors: F ter Borg; S Smorenburg; R A de Man; R C Rietbroek; R A Chamuleau; E A Jones
Journal: Dig Dis Sci Date: 1998-10 Impact factor: 3.199

6. Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.

Authors: Meng-Shen Dai; Pei-Fen Wu; Jang-Jih Lu; Rong-Yaun Shyu; Tsu-Yi Chao
Journal: Support Care Cancer Date: 2004-03 Impact factor: 3.603

Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.

1. Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

2. Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.

3. An argument for the universal prophylaxis of hepatitis B infection in patients receiving rituximab: a 7-year institutional experience of hepatitis screening.

4. The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies.

5. Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.

6. Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.

7. Association between hepatitis B virus and pancreatic cancer.

8. Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders.

9. Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma.

10. Rituximab administration and reactivation of HBV.